Rheumatoid Arthritis Medicine Market, Global Outlook and Forecast 2022-2028
Rheumatoid Arthritis is an autoimmune disease that causes pain, swelling, and stiffness in the joints, and may cause severe joint damage, loss of function, and disability. The disease may last from months to a lifetime, and symptoms may improve and worsen over time.
This report contains market size and forecasts of Rheumatoid Arthritis Medicine in global, including the following market information:
Global Rheumatoid Arthritis Medicine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Rheumatoid Arthritis Medicine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Rheumatoid Arthritis Medicine companies in 2021 (%)
The global Rheumatoid Arthritis Medicine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Prescription Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Rheumatoid Arthritis Medicine include AbbVie Inc, Hoffman-La Roche AG, Amgen Inc, Pfizer Inc, Bristol-Myers Squibb Co, Johnson & Johnson, UCB Biosciences Inc, Mitsubishi Tanabe Pharma Corp and Biogen Inc and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Rheumatoid Arthritis Medicine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rheumatoid Arthritis Medicine Market, By Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Rheumatoid Arthritis Medicine Market Segment Percentages, By Type, 2021 (%)
Global Rheumatoid Arthritis Medicine Market Segment Percentages, By Application, 2021 (%)
Global Rheumatoid Arthritis Medicine Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Rheumatoid Arthritis Medicine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Rheumatoid Arthritis Medicine revenues share in global market, 2021 (%)
Key companies Rheumatoid Arthritis Medicine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Rheumatoid Arthritis Medicine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Rheumatoid Arthritis Medicine in global, including the following market information:
Global Rheumatoid Arthritis Medicine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Rheumatoid Arthritis Medicine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Rheumatoid Arthritis Medicine companies in 2021 (%)
The global Rheumatoid Arthritis Medicine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Prescription Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Rheumatoid Arthritis Medicine include AbbVie Inc, Hoffman-La Roche AG, Amgen Inc, Pfizer Inc, Bristol-Myers Squibb Co, Johnson & Johnson, UCB Biosciences Inc, Mitsubishi Tanabe Pharma Corp and Biogen Inc and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Rheumatoid Arthritis Medicine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rheumatoid Arthritis Medicine Market, By Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Rheumatoid Arthritis Medicine Market Segment Percentages, By Type, 2021 (%)
- Prescription Drugs
- OTC Drugs
Global Rheumatoid Arthritis Medicine Market Segment Percentages, By Application, 2021 (%)
- Hospital
- Clinics
- Others
Global Rheumatoid Arthritis Medicine Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Rheumatoid Arthritis Medicine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Rheumatoid Arthritis Medicine revenues share in global market, 2021 (%)
Key companies Rheumatoid Arthritis Medicine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Rheumatoid Arthritis Medicine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- AbbVie Inc
- Hoffman-La Roche AG
- Amgen Inc
- Pfizer Inc
- Bristol-Myers Squibb Co
- Johnson & Johnson
- UCB Biosciences Inc
- Mitsubishi Tanabe Pharma Corp
- Biogen Inc
- Merck & Co
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Rheumatoid Arthritis Medicine Market Definition
1.2 Market Segments
1.2.1 Market By Type
1.2.2 Market By Application
1.3 Global Rheumatoid Arthritis Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL RHEUMATOID ARTHRITIS MEDICINE OVERALL MARKET SIZE
2.1 Global Rheumatoid Arthritis Medicine Market Size: 2021 VS 2028
2.2 Global Rheumatoid Arthritis Medicine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Rheumatoid Arthritis Medicine Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Rheumatoid Arthritis Medicine Players in Global Market
3.2 Top Global Rheumatoid Arthritis Medicine Companies Ranked by Revenue
3.3 Global Rheumatoid Arthritis Medicine Revenue by Companies
3.4 Global Rheumatoid Arthritis Medicine Sales by Companies
3.5 Global Rheumatoid Arthritis Medicine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Rheumatoid Arthritis Medicine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Rheumatoid Arthritis Medicine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Rheumatoid Arthritis Medicine Players in Global Market
3.8.1 List of Global Tier 1 Rheumatoid Arthritis Medicine Companies
3.8.2 List of Global Tier 2 and Tier 3 Rheumatoid Arthritis Medicine Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Rheumatoid Arthritis Medicine Market Size Markets, 2021 & 2028
4.1.2 Prescription Drugs
4.1.3 OTC Drugs
4.2 By Type - Global Rheumatoid Arthritis Medicine Revenue & Forecasts
4.2.1 By Type - Global Rheumatoid Arthritis Medicine Revenue, 2017-2022
4.2.2 By Type - Global Rheumatoid Arthritis Medicine Revenue, 2023-2028
4.2.3 By Type - Global Rheumatoid Arthritis Medicine Revenue Market Share, 2017-2028
4.3 By Type - Global Rheumatoid Arthritis Medicine Sales & Forecasts
4.3.1 By Type - Global Rheumatoid Arthritis Medicine Sales, 2017-2022
4.3.2 By Type - Global Rheumatoid Arthritis Medicine Sales, 2023-2028
4.3.3 By Type - Global Rheumatoid Arthritis Medicine Sales Market Share, 2017-2028
4.4 By Type - Global Rheumatoid Arthritis Medicine Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Rheumatoid Arthritis Medicine Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Rheumatoid Arthritis Medicine Revenue & Forecasts
5.2.1 By Application - Global Rheumatoid Arthritis Medicine Revenue, 2017-2022
5.2.2 By Application - Global Rheumatoid Arthritis Medicine Revenue, 2023-2028
5.2.3 By Application - Global Rheumatoid Arthritis Medicine Revenue Market Share, 2017-2028
5.3 By Application - Global Rheumatoid Arthritis Medicine Sales & Forecasts
5.3.1 By Application - Global Rheumatoid Arthritis Medicine Sales, 2017-2022
5.3.2 By Application - Global Rheumatoid Arthritis Medicine Sales, 2023-2028
5.3.3 By Application - Global Rheumatoid Arthritis Medicine Sales Market Share, 2017-2028
5.4 By Application - Global Rheumatoid Arthritis Medicine Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Rheumatoid Arthritis Medicine Market Size, 2021 & 2028
6.2 By Region - Global Rheumatoid Arthritis Medicine Revenue & Forecasts
6.2.1 By Region - Global Rheumatoid Arthritis Medicine Revenue, 2017-2022
6.2.2 By Region - Global Rheumatoid Arthritis Medicine Revenue, 2023-2028
6.2.3 By Region - Global Rheumatoid Arthritis Medicine Revenue Market Share, 2017-2028
6.3 By Region - Global Rheumatoid Arthritis Medicine Sales & Forecasts
6.3.1 By Region - Global Rheumatoid Arthritis Medicine Sales, 2017-2022
6.3.2 By Region - Global Rheumatoid Arthritis Medicine Sales, 2023-2028
6.3.3 By Region - Global Rheumatoid Arthritis Medicine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Rheumatoid Arthritis Medicine Revenue, 2017-2028
6.4.2 By Country - North America Rheumatoid Arthritis Medicine Sales, 2017-2028
6.4.3 US Rheumatoid Arthritis Medicine Market Size, 2017-2028
6.4.4 Canada Rheumatoid Arthritis Medicine Market Size, 2017-2028
6.4.5 Mexico Rheumatoid Arthritis Medicine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Rheumatoid Arthritis Medicine Revenue, 2017-2028
6.5.2 By Country - Europe Rheumatoid Arthritis Medicine Sales, 2017-2028
6.5.3 Germany Rheumatoid Arthritis Medicine Market Size, 2017-2028
6.5.4 France Rheumatoid Arthritis Medicine Market Size, 2017-2028
6.5.5 U.K. Rheumatoid Arthritis Medicine Market Size, 2017-2028
6.5.6 Italy Rheumatoid Arthritis Medicine Market Size, 2017-2028
6.5.7 Russia Rheumatoid Arthritis Medicine Market Size, 2017-2028
6.5.8 Nordic Countries Rheumatoid Arthritis Medicine Market Size, 2017-2028
6.5.9 Benelux Rheumatoid Arthritis Medicine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Rheumatoid Arthritis Medicine Revenue, 2017-2028
6.6.2 By Region - Asia Rheumatoid Arthritis Medicine Sales, 2017-2028
6.6.3 China Rheumatoid Arthritis Medicine Market Size, 2017-2028
6.6.4 Japan Rheumatoid Arthritis Medicine Market Size, 2017-2028
6.6.5 South Korea Rheumatoid Arthritis Medicine Market Size, 2017-2028
6.6.6 Southeast Asia Rheumatoid Arthritis Medicine Market Size, 2017-2028
6.6.7 India Rheumatoid Arthritis Medicine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Rheumatoid Arthritis Medicine Revenue, 2017-2028
6.7.2 By Country - South America Rheumatoid Arthritis Medicine Sales, 2017-2028
6.7.3 Brazil Rheumatoid Arthritis Medicine Market Size, 2017-2028
6.7.4 Argentina Rheumatoid Arthritis Medicine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Rheumatoid Arthritis Medicine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Rheumatoid Arthritis Medicine Sales, 2017-2028
6.8.3 Turkey Rheumatoid Arthritis Medicine Market Size, 2017-2028
6.8.4 Israel Rheumatoid Arthritis Medicine Market Size, 2017-2028
6.8.5 Saudi Arabia Rheumatoid Arthritis Medicine Market Size, 2017-2028
6.8.6 UAE Rheumatoid Arthritis Medicine Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 AbbVie Inc
7.1.1 AbbVie Inc Corporate Summary
7.1.2 AbbVie Inc Business Overview
7.1.3 AbbVie Inc Rheumatoid Arthritis Medicine Major Product Offerings
7.1.4 AbbVie Inc Rheumatoid Arthritis Medicine Sales and Revenue in Global (2017-2022)
7.1.5 AbbVie Inc Key News
7.2 Hoffman-La Roche AG
7.2.1 Hoffman-La Roche AG Corporate Summary
7.2.2 Hoffman-La Roche AG Business Overview
7.2.3 Hoffman-La Roche AG Rheumatoid Arthritis Medicine Major Product Offerings
7.2.4 Hoffman-La Roche AG Rheumatoid Arthritis Medicine Sales and Revenue in Global (2017-2022)
7.2.5 Hoffman-La Roche AG Key News
7.3 Amgen Inc
7.3.1 Amgen Inc Corporate Summary
7.3.2 Amgen Inc Business Overview
7.3.3 Amgen Inc Rheumatoid Arthritis Medicine Major Product Offerings
7.3.4 Amgen Inc Rheumatoid Arthritis Medicine Sales and Revenue in Global (2017-2022)
7.3.5 Amgen Inc Key News
7.4 Pfizer Inc
7.4.1 Pfizer Inc Corporate Summary
7.4.2 Pfizer Inc Business Overview
7.4.3 Pfizer Inc Rheumatoid Arthritis Medicine Major Product Offerings
7.4.4 Pfizer Inc Rheumatoid Arthritis Medicine Sales and Revenue in Global (2017-2022)
7.4.5 Pfizer Inc Key News
7.5 Bristol-Myers Squibb Co
7.5.1 Bristol-Myers Squibb Co Corporate Summary
7.5.2 Bristol-Myers Squibb Co Business Overview
7.5.3 Bristol-Myers Squibb Co Rheumatoid Arthritis Medicine Major Product Offerings
7.5.4 Bristol-Myers Squibb Co Rheumatoid Arthritis Medicine Sales and Revenue in Global (2017-2022)
7.5.5 Bristol-Myers Squibb Co Key News
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Corporate Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Rheumatoid Arthritis Medicine Major Product Offerings
7.6.4 Johnson & Johnson Rheumatoid Arthritis Medicine Sales and Revenue in Global (2017-2022)
7.6.5 Johnson & Johnson Key News
7.7 UCB Biosciences Inc
7.7.1 UCB Biosciences Inc Corporate Summary
7.7.2 UCB Biosciences Inc Business Overview
7.7.3 UCB Biosciences Inc Rheumatoid Arthritis Medicine Major Product Offerings
7.7.4 UCB Biosciences Inc Rheumatoid Arthritis Medicine Sales and Revenue in Global (2017-2022)
7.7.5 UCB Biosciences Inc Key News
7.8 Mitsubishi Tanabe Pharma Corp
7.8.1 Mitsubishi Tanabe Pharma Corp Corporate Summary
7.8.2 Mitsubishi Tanabe Pharma Corp Business Overview
7.8.3 Mitsubishi Tanabe Pharma Corp Rheumatoid Arthritis Medicine Major Product Offerings
7.8.4 Mitsubishi Tanabe Pharma Corp Rheumatoid Arthritis Medicine Sales and Revenue in Global (2017-2022)
7.8.5 Mitsubishi Tanabe Pharma Corp Key News
7.9 Biogen Inc
7.9.1 Biogen Inc Corporate Summary
7.9.2 Biogen Inc Business Overview
7.9.3 Biogen Inc Rheumatoid Arthritis Medicine Major Product Offerings
7.9.4 Biogen Inc Rheumatoid Arthritis Medicine Sales and Revenue in Global (2017-2022)
7.9.5 Biogen Inc Key News
7.10 Merck & Co
7.10.1 Merck & Co Corporate Summary
7.10.2 Merck & Co Business Overview
7.10.3 Merck & Co Rheumatoid Arthritis Medicine Major Product Offerings
7.10.4 Merck & Co Rheumatoid Arthritis Medicine Sales and Revenue in Global (2017-2022)
7.10.5 Merck & Co Key News
8 GLOBAL RHEUMATOID ARTHRITIS MEDICINE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Rheumatoid Arthritis Medicine Production Capacity, 2017-2028
8.2 Rheumatoid Arthritis Medicine Production Capacity of Key Manufacturers in Global Market
8.3 Global Rheumatoid Arthritis Medicine Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 RHEUMATOID ARTHRITIS MEDICINE SUPPLY CHAIN ANALYSIS
10.1 Rheumatoid Arthritis Medicine Industry Value Chain
10.2 Rheumatoid Arthritis Medicine Upstream Market
10.3 Rheumatoid Arthritis Medicine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Rheumatoid Arthritis Medicine Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Rheumatoid Arthritis Medicine Market Definition
1.2 Market Segments
1.2.1 Market By Type
1.2.2 Market By Application
1.3 Global Rheumatoid Arthritis Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL RHEUMATOID ARTHRITIS MEDICINE OVERALL MARKET SIZE
2.1 Global Rheumatoid Arthritis Medicine Market Size: 2021 VS 2028
2.2 Global Rheumatoid Arthritis Medicine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Rheumatoid Arthritis Medicine Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Rheumatoid Arthritis Medicine Players in Global Market
3.2 Top Global Rheumatoid Arthritis Medicine Companies Ranked by Revenue
3.3 Global Rheumatoid Arthritis Medicine Revenue by Companies
3.4 Global Rheumatoid Arthritis Medicine Sales by Companies
3.5 Global Rheumatoid Arthritis Medicine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Rheumatoid Arthritis Medicine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Rheumatoid Arthritis Medicine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Rheumatoid Arthritis Medicine Players in Global Market
3.8.1 List of Global Tier 1 Rheumatoid Arthritis Medicine Companies
3.8.2 List of Global Tier 2 and Tier 3 Rheumatoid Arthritis Medicine Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Rheumatoid Arthritis Medicine Market Size Markets, 2021 & 2028
4.1.2 Prescription Drugs
4.1.3 OTC Drugs
4.2 By Type - Global Rheumatoid Arthritis Medicine Revenue & Forecasts
4.2.1 By Type - Global Rheumatoid Arthritis Medicine Revenue, 2017-2022
4.2.2 By Type - Global Rheumatoid Arthritis Medicine Revenue, 2023-2028
4.2.3 By Type - Global Rheumatoid Arthritis Medicine Revenue Market Share, 2017-2028
4.3 By Type - Global Rheumatoid Arthritis Medicine Sales & Forecasts
4.3.1 By Type - Global Rheumatoid Arthritis Medicine Sales, 2017-2022
4.3.2 By Type - Global Rheumatoid Arthritis Medicine Sales, 2023-2028
4.3.3 By Type - Global Rheumatoid Arthritis Medicine Sales Market Share, 2017-2028
4.4 By Type - Global Rheumatoid Arthritis Medicine Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Rheumatoid Arthritis Medicine Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Rheumatoid Arthritis Medicine Revenue & Forecasts
5.2.1 By Application - Global Rheumatoid Arthritis Medicine Revenue, 2017-2022
5.2.2 By Application - Global Rheumatoid Arthritis Medicine Revenue, 2023-2028
5.2.3 By Application - Global Rheumatoid Arthritis Medicine Revenue Market Share, 2017-2028
5.3 By Application - Global Rheumatoid Arthritis Medicine Sales & Forecasts
5.3.1 By Application - Global Rheumatoid Arthritis Medicine Sales, 2017-2022
5.3.2 By Application - Global Rheumatoid Arthritis Medicine Sales, 2023-2028
5.3.3 By Application - Global Rheumatoid Arthritis Medicine Sales Market Share, 2017-2028
5.4 By Application - Global Rheumatoid Arthritis Medicine Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Rheumatoid Arthritis Medicine Market Size, 2021 & 2028
6.2 By Region - Global Rheumatoid Arthritis Medicine Revenue & Forecasts
6.2.1 By Region - Global Rheumatoid Arthritis Medicine Revenue, 2017-2022
6.2.2 By Region - Global Rheumatoid Arthritis Medicine Revenue, 2023-2028
6.2.3 By Region - Global Rheumatoid Arthritis Medicine Revenue Market Share, 2017-2028
6.3 By Region - Global Rheumatoid Arthritis Medicine Sales & Forecasts
6.3.1 By Region - Global Rheumatoid Arthritis Medicine Sales, 2017-2022
6.3.2 By Region - Global Rheumatoid Arthritis Medicine Sales, 2023-2028
6.3.3 By Region - Global Rheumatoid Arthritis Medicine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Rheumatoid Arthritis Medicine Revenue, 2017-2028
6.4.2 By Country - North America Rheumatoid Arthritis Medicine Sales, 2017-2028
6.4.3 US Rheumatoid Arthritis Medicine Market Size, 2017-2028
6.4.4 Canada Rheumatoid Arthritis Medicine Market Size, 2017-2028
6.4.5 Mexico Rheumatoid Arthritis Medicine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Rheumatoid Arthritis Medicine Revenue, 2017-2028
6.5.2 By Country - Europe Rheumatoid Arthritis Medicine Sales, 2017-2028
6.5.3 Germany Rheumatoid Arthritis Medicine Market Size, 2017-2028
6.5.4 France Rheumatoid Arthritis Medicine Market Size, 2017-2028
6.5.5 U.K. Rheumatoid Arthritis Medicine Market Size, 2017-2028
6.5.6 Italy Rheumatoid Arthritis Medicine Market Size, 2017-2028
6.5.7 Russia Rheumatoid Arthritis Medicine Market Size, 2017-2028
6.5.8 Nordic Countries Rheumatoid Arthritis Medicine Market Size, 2017-2028
6.5.9 Benelux Rheumatoid Arthritis Medicine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Rheumatoid Arthritis Medicine Revenue, 2017-2028
6.6.2 By Region - Asia Rheumatoid Arthritis Medicine Sales, 2017-2028
6.6.3 China Rheumatoid Arthritis Medicine Market Size, 2017-2028
6.6.4 Japan Rheumatoid Arthritis Medicine Market Size, 2017-2028
6.6.5 South Korea Rheumatoid Arthritis Medicine Market Size, 2017-2028
6.6.6 Southeast Asia Rheumatoid Arthritis Medicine Market Size, 2017-2028
6.6.7 India Rheumatoid Arthritis Medicine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Rheumatoid Arthritis Medicine Revenue, 2017-2028
6.7.2 By Country - South America Rheumatoid Arthritis Medicine Sales, 2017-2028
6.7.3 Brazil Rheumatoid Arthritis Medicine Market Size, 2017-2028
6.7.4 Argentina Rheumatoid Arthritis Medicine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Rheumatoid Arthritis Medicine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Rheumatoid Arthritis Medicine Sales, 2017-2028
6.8.3 Turkey Rheumatoid Arthritis Medicine Market Size, 2017-2028
6.8.4 Israel Rheumatoid Arthritis Medicine Market Size, 2017-2028
6.8.5 Saudi Arabia Rheumatoid Arthritis Medicine Market Size, 2017-2028
6.8.6 UAE Rheumatoid Arthritis Medicine Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 AbbVie Inc
7.1.1 AbbVie Inc Corporate Summary
7.1.2 AbbVie Inc Business Overview
7.1.3 AbbVie Inc Rheumatoid Arthritis Medicine Major Product Offerings
7.1.4 AbbVie Inc Rheumatoid Arthritis Medicine Sales and Revenue in Global (2017-2022)
7.1.5 AbbVie Inc Key News
7.2 Hoffman-La Roche AG
7.2.1 Hoffman-La Roche AG Corporate Summary
7.2.2 Hoffman-La Roche AG Business Overview
7.2.3 Hoffman-La Roche AG Rheumatoid Arthritis Medicine Major Product Offerings
7.2.4 Hoffman-La Roche AG Rheumatoid Arthritis Medicine Sales and Revenue in Global (2017-2022)
7.2.5 Hoffman-La Roche AG Key News
7.3 Amgen Inc
7.3.1 Amgen Inc Corporate Summary
7.3.2 Amgen Inc Business Overview
7.3.3 Amgen Inc Rheumatoid Arthritis Medicine Major Product Offerings
7.3.4 Amgen Inc Rheumatoid Arthritis Medicine Sales and Revenue in Global (2017-2022)
7.3.5 Amgen Inc Key News
7.4 Pfizer Inc
7.4.1 Pfizer Inc Corporate Summary
7.4.2 Pfizer Inc Business Overview
7.4.3 Pfizer Inc Rheumatoid Arthritis Medicine Major Product Offerings
7.4.4 Pfizer Inc Rheumatoid Arthritis Medicine Sales and Revenue in Global (2017-2022)
7.4.5 Pfizer Inc Key News
7.5 Bristol-Myers Squibb Co
7.5.1 Bristol-Myers Squibb Co Corporate Summary
7.5.2 Bristol-Myers Squibb Co Business Overview
7.5.3 Bristol-Myers Squibb Co Rheumatoid Arthritis Medicine Major Product Offerings
7.5.4 Bristol-Myers Squibb Co Rheumatoid Arthritis Medicine Sales and Revenue in Global (2017-2022)
7.5.5 Bristol-Myers Squibb Co Key News
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Corporate Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Rheumatoid Arthritis Medicine Major Product Offerings
7.6.4 Johnson & Johnson Rheumatoid Arthritis Medicine Sales and Revenue in Global (2017-2022)
7.6.5 Johnson & Johnson Key News
7.7 UCB Biosciences Inc
7.7.1 UCB Biosciences Inc Corporate Summary
7.7.2 UCB Biosciences Inc Business Overview
7.7.3 UCB Biosciences Inc Rheumatoid Arthritis Medicine Major Product Offerings
7.7.4 UCB Biosciences Inc Rheumatoid Arthritis Medicine Sales and Revenue in Global (2017-2022)
7.7.5 UCB Biosciences Inc Key News
7.8 Mitsubishi Tanabe Pharma Corp
7.8.1 Mitsubishi Tanabe Pharma Corp Corporate Summary
7.8.2 Mitsubishi Tanabe Pharma Corp Business Overview
7.8.3 Mitsubishi Tanabe Pharma Corp Rheumatoid Arthritis Medicine Major Product Offerings
7.8.4 Mitsubishi Tanabe Pharma Corp Rheumatoid Arthritis Medicine Sales and Revenue in Global (2017-2022)
7.8.5 Mitsubishi Tanabe Pharma Corp Key News
7.9 Biogen Inc
7.9.1 Biogen Inc Corporate Summary
7.9.2 Biogen Inc Business Overview
7.9.3 Biogen Inc Rheumatoid Arthritis Medicine Major Product Offerings
7.9.4 Biogen Inc Rheumatoid Arthritis Medicine Sales and Revenue in Global (2017-2022)
7.9.5 Biogen Inc Key News
7.10 Merck & Co
7.10.1 Merck & Co Corporate Summary
7.10.2 Merck & Co Business Overview
7.10.3 Merck & Co Rheumatoid Arthritis Medicine Major Product Offerings
7.10.4 Merck & Co Rheumatoid Arthritis Medicine Sales and Revenue in Global (2017-2022)
7.10.5 Merck & Co Key News
8 GLOBAL RHEUMATOID ARTHRITIS MEDICINE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Rheumatoid Arthritis Medicine Production Capacity, 2017-2028
8.2 Rheumatoid Arthritis Medicine Production Capacity of Key Manufacturers in Global Market
8.3 Global Rheumatoid Arthritis Medicine Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 RHEUMATOID ARTHRITIS MEDICINE SUPPLY CHAIN ANALYSIS
10.1 Rheumatoid Arthritis Medicine Industry Value Chain
10.2 Rheumatoid Arthritis Medicine Upstream Market
10.3 Rheumatoid Arthritis Medicine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Rheumatoid Arthritis Medicine Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Rheumatoid Arthritis Medicine in Global Market
Table 2. Top Rheumatoid Arthritis Medicine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Rheumatoid Arthritis Medicine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Rheumatoid Arthritis Medicine Revenue Share by Companies, 2017-2022
Table 5. Global Rheumatoid Arthritis Medicine Sales by Companies, (K Units), 2017-2022
Table 6. Global Rheumatoid Arthritis Medicine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Rheumatoid Arthritis Medicine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Rheumatoid Arthritis Medicine Product Type
Table 9. List of Global Tier 1 Rheumatoid Arthritis Medicine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Rheumatoid Arthritis Medicine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Rheumatoid Arthritis Medicine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Rheumatoid Arthritis Medicine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Rheumatoid Arthritis Medicine Sales (K Units), 2017-2022
Table 15. By Type - Global Rheumatoid Arthritis Medicine Sales (K Units), 2023-2028
Table 16. By Application – Global Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Rheumatoid Arthritis Medicine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Rheumatoid Arthritis Medicine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Rheumatoid Arthritis Medicine Sales (K Units), 2017-2022
Table 20. By Application - Global Rheumatoid Arthritis Medicine Sales (K Units), 2023-2028
Table 21. By Region – Global Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Rheumatoid Arthritis Medicine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Rheumatoid Arthritis Medicine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Rheumatoid Arthritis Medicine Sales (K Units), 2017-2022
Table 25. By Region - Global Rheumatoid Arthritis Medicine Sales (K Units), 2023-2028
Table 26. By Country - North America Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Rheumatoid Arthritis Medicine Sales, (K Units), 2017-2022
Table 29. By Country - North America Rheumatoid Arthritis Medicine Sales, (K Units), 2023-2028
Table 30. By Country - Europe Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Rheumatoid Arthritis Medicine Sales, (K Units), 2017-2022
Table 33. By Country - Europe Rheumatoid Arthritis Medicine Sales, (K Units), 2023-2028
Table 34. By Region - Asia Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Rheumatoid Arthritis Medicine Sales, (K Units), 2017-2022
Table 37. By Region - Asia Rheumatoid Arthritis Medicine Sales, (K Units), 2023-2028
Table 38. By Country - South America Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Rheumatoid Arthritis Medicine Sales, (K Units), 2017-2022
Table 41. By Country - South America Rheumatoid Arthritis Medicine Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Rheumatoid Arthritis Medicine Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Rheumatoid Arthritis Medicine Sales, (K Units), 2023-2028
Table 46. AbbVie Inc Corporate Summary
Table 47. AbbVie Inc Rheumatoid Arthritis Medicine Product Offerings
Table 48. AbbVie Inc Rheumatoid Arthritis Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Hoffman-La Roche AG Corporate Summary
Table 50. Hoffman-La Roche AG Rheumatoid Arthritis Medicine Product Offerings
Table 51. Hoffman-La Roche AG Rheumatoid Arthritis Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Amgen Inc Corporate Summary
Table 53. Amgen Inc Rheumatoid Arthritis Medicine Product Offerings
Table 54. Amgen Inc Rheumatoid Arthritis Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Pfizer Inc Corporate Summary
Table 56. Pfizer Inc Rheumatoid Arthritis Medicine Product Offerings
Table 57. Pfizer Inc Rheumatoid Arthritis Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Bristol-Myers Squibb Co Corporate Summary
Table 59. Bristol-Myers Squibb Co Rheumatoid Arthritis Medicine Product Offerings
Table 60. Bristol-Myers Squibb Co Rheumatoid Arthritis Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Johnson & Johnson Corporate Summary
Table 62. Johnson & Johnson Rheumatoid Arthritis Medicine Product Offerings
Table 63. Johnson & Johnson Rheumatoid Arthritis Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. UCB Biosciences Inc Corporate Summary
Table 65. UCB Biosciences Inc Rheumatoid Arthritis Medicine Product Offerings
Table 66. UCB Biosciences Inc Rheumatoid Arthritis Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Mitsubishi Tanabe Pharma Corp Corporate Summary
Table 68. Mitsubishi Tanabe Pharma Corp Rheumatoid Arthritis Medicine Product Offerings
Table 69. Mitsubishi Tanabe Pharma Corp Rheumatoid Arthritis Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Biogen Inc Corporate Summary
Table 71. Biogen Inc Rheumatoid Arthritis Medicine Product Offerings
Table 72. Biogen Inc Rheumatoid Arthritis Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Merck & Co Corporate Summary
Table 74. Merck & Co Rheumatoid Arthritis Medicine Product Offerings
Table 75. Merck & Co Rheumatoid Arthritis Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Rheumatoid Arthritis Medicine Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 77. Global Rheumatoid Arthritis Medicine Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Rheumatoid Arthritis Medicine Production by Region, 2017-2022 (K Units)
Table 79. Global Rheumatoid Arthritis Medicine Production by Region, 2023-2028 (K Units)
Table 80. Rheumatoid Arthritis Medicine Market Opportunities & Trends in Global Market
Table 81. Rheumatoid Arthritis Medicine Market Drivers in Global Market
Table 82. Rheumatoid Arthritis Medicine Market Restraints in Global Market
Table 83. Rheumatoid Arthritis Medicine Raw Materials
Table 84. Rheumatoid Arthritis Medicine Raw Materials Suppliers in Global Market
Table 85. Typical Rheumatoid Arthritis Medicine Downstream
Table 86. Rheumatoid Arthritis Medicine Downstream Clients in Global Market
Table 87. Rheumatoid Arthritis Medicine Distributors and Sales Agents in Global Market
Table 1. Key Players of Rheumatoid Arthritis Medicine in Global Market
Table 2. Top Rheumatoid Arthritis Medicine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Rheumatoid Arthritis Medicine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Rheumatoid Arthritis Medicine Revenue Share by Companies, 2017-2022
Table 5. Global Rheumatoid Arthritis Medicine Sales by Companies, (K Units), 2017-2022
Table 6. Global Rheumatoid Arthritis Medicine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Rheumatoid Arthritis Medicine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Rheumatoid Arthritis Medicine Product Type
Table 9. List of Global Tier 1 Rheumatoid Arthritis Medicine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Rheumatoid Arthritis Medicine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Rheumatoid Arthritis Medicine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Rheumatoid Arthritis Medicine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Rheumatoid Arthritis Medicine Sales (K Units), 2017-2022
Table 15. By Type - Global Rheumatoid Arthritis Medicine Sales (K Units), 2023-2028
Table 16. By Application – Global Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Rheumatoid Arthritis Medicine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Rheumatoid Arthritis Medicine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Rheumatoid Arthritis Medicine Sales (K Units), 2017-2022
Table 20. By Application - Global Rheumatoid Arthritis Medicine Sales (K Units), 2023-2028
Table 21. By Region – Global Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Rheumatoid Arthritis Medicine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Rheumatoid Arthritis Medicine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Rheumatoid Arthritis Medicine Sales (K Units), 2017-2022
Table 25. By Region - Global Rheumatoid Arthritis Medicine Sales (K Units), 2023-2028
Table 26. By Country - North America Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Rheumatoid Arthritis Medicine Sales, (K Units), 2017-2022
Table 29. By Country - North America Rheumatoid Arthritis Medicine Sales, (K Units), 2023-2028
Table 30. By Country - Europe Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Rheumatoid Arthritis Medicine Sales, (K Units), 2017-2022
Table 33. By Country - Europe Rheumatoid Arthritis Medicine Sales, (K Units), 2023-2028
Table 34. By Region - Asia Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Rheumatoid Arthritis Medicine Sales, (K Units), 2017-2022
Table 37. By Region - Asia Rheumatoid Arthritis Medicine Sales, (K Units), 2023-2028
Table 38. By Country - South America Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Rheumatoid Arthritis Medicine Sales, (K Units), 2017-2022
Table 41. By Country - South America Rheumatoid Arthritis Medicine Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Rheumatoid Arthritis Medicine Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Rheumatoid Arthritis Medicine Sales, (K Units), 2023-2028
Table 46. AbbVie Inc Corporate Summary
Table 47. AbbVie Inc Rheumatoid Arthritis Medicine Product Offerings
Table 48. AbbVie Inc Rheumatoid Arthritis Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Hoffman-La Roche AG Corporate Summary
Table 50. Hoffman-La Roche AG Rheumatoid Arthritis Medicine Product Offerings
Table 51. Hoffman-La Roche AG Rheumatoid Arthritis Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Amgen Inc Corporate Summary
Table 53. Amgen Inc Rheumatoid Arthritis Medicine Product Offerings
Table 54. Amgen Inc Rheumatoid Arthritis Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Pfizer Inc Corporate Summary
Table 56. Pfizer Inc Rheumatoid Arthritis Medicine Product Offerings
Table 57. Pfizer Inc Rheumatoid Arthritis Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Bristol-Myers Squibb Co Corporate Summary
Table 59. Bristol-Myers Squibb Co Rheumatoid Arthritis Medicine Product Offerings
Table 60. Bristol-Myers Squibb Co Rheumatoid Arthritis Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Johnson & Johnson Corporate Summary
Table 62. Johnson & Johnson Rheumatoid Arthritis Medicine Product Offerings
Table 63. Johnson & Johnson Rheumatoid Arthritis Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. UCB Biosciences Inc Corporate Summary
Table 65. UCB Biosciences Inc Rheumatoid Arthritis Medicine Product Offerings
Table 66. UCB Biosciences Inc Rheumatoid Arthritis Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Mitsubishi Tanabe Pharma Corp Corporate Summary
Table 68. Mitsubishi Tanabe Pharma Corp Rheumatoid Arthritis Medicine Product Offerings
Table 69. Mitsubishi Tanabe Pharma Corp Rheumatoid Arthritis Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Biogen Inc Corporate Summary
Table 71. Biogen Inc Rheumatoid Arthritis Medicine Product Offerings
Table 72. Biogen Inc Rheumatoid Arthritis Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Merck & Co Corporate Summary
Table 74. Merck & Co Rheumatoid Arthritis Medicine Product Offerings
Table 75. Merck & Co Rheumatoid Arthritis Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Rheumatoid Arthritis Medicine Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 77. Global Rheumatoid Arthritis Medicine Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Rheumatoid Arthritis Medicine Production by Region, 2017-2022 (K Units)
Table 79. Global Rheumatoid Arthritis Medicine Production by Region, 2023-2028 (K Units)
Table 80. Rheumatoid Arthritis Medicine Market Opportunities & Trends in Global Market
Table 81. Rheumatoid Arthritis Medicine Market Drivers in Global Market
Table 82. Rheumatoid Arthritis Medicine Market Restraints in Global Market
Table 83. Rheumatoid Arthritis Medicine Raw Materials
Table 84. Rheumatoid Arthritis Medicine Raw Materials Suppliers in Global Market
Table 85. Typical Rheumatoid Arthritis Medicine Downstream
Table 86. Rheumatoid Arthritis Medicine Downstream Clients in Global Market
Table 87. Rheumatoid Arthritis Medicine Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Rheumatoid Arthritis Medicine Segment By Type
Figure 2. Rheumatoid Arthritis Medicine Segment By Application
Figure 3. Global Rheumatoid Arthritis Medicine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Rheumatoid Arthritis Medicine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Rheumatoid Arthritis Medicine Revenue, 2017-2028 (US$, Mn)
Figure 7. Rheumatoid Arthritis Medicine Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Rheumatoid Arthritis Medicine Revenue in 2021
Figure 9. By Type - Global Rheumatoid Arthritis Medicine Sales Market Share, 2017-2028
Figure 10. By Type - Global Rheumatoid Arthritis Medicine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Rheumatoid Arthritis Medicine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Rheumatoid Arthritis Medicine Sales Market Share, 2017-2028
Figure 13. By Application - Global Rheumatoid Arthritis Medicine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Rheumatoid Arthritis Medicine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Rheumatoid Arthritis Medicine Sales Market Share, 2017-2028
Figure 16. By Region - Global Rheumatoid Arthritis Medicine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Rheumatoid Arthritis Medicine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Rheumatoid Arthritis Medicine Sales Market Share, 2017-2028
Figure 19. US Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Rheumatoid Arthritis Medicine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Rheumatoid Arthritis Medicine Sales Market Share, 2017-2028
Figure 24. Germany Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2028
Figure 25. France Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Rheumatoid Arthritis Medicine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Rheumatoid Arthritis Medicine Sales Market Share, 2017-2028
Figure 33. China Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2028
Figure 37. India Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Rheumatoid Arthritis Medicine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Rheumatoid Arthritis Medicine Sales Market Share, 2017-2028
Figure 40. Brazil Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Rheumatoid Arthritis Medicine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Rheumatoid Arthritis Medicine Sales Market Share, 2017-2028
Figure 44. Turkey Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Rheumatoid Arthritis Medicine Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Rheumatoid Arthritis Medicine by Region, 2021 VS 2028
Figure 50. Rheumatoid Arthritis Medicine Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Rheumatoid Arthritis Medicine Segment By Type
Figure 2. Rheumatoid Arthritis Medicine Segment By Application
Figure 3. Global Rheumatoid Arthritis Medicine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Rheumatoid Arthritis Medicine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Rheumatoid Arthritis Medicine Revenue, 2017-2028 (US$, Mn)
Figure 7. Rheumatoid Arthritis Medicine Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Rheumatoid Arthritis Medicine Revenue in 2021
Figure 9. By Type - Global Rheumatoid Arthritis Medicine Sales Market Share, 2017-2028
Figure 10. By Type - Global Rheumatoid Arthritis Medicine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Rheumatoid Arthritis Medicine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Rheumatoid Arthritis Medicine Sales Market Share, 2017-2028
Figure 13. By Application - Global Rheumatoid Arthritis Medicine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Rheumatoid Arthritis Medicine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Rheumatoid Arthritis Medicine Sales Market Share, 2017-2028
Figure 16. By Region - Global Rheumatoid Arthritis Medicine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Rheumatoid Arthritis Medicine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Rheumatoid Arthritis Medicine Sales Market Share, 2017-2028
Figure 19. US Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Rheumatoid Arthritis Medicine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Rheumatoid Arthritis Medicine Sales Market Share, 2017-2028
Figure 24. Germany Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2028
Figure 25. France Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Rheumatoid Arthritis Medicine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Rheumatoid Arthritis Medicine Sales Market Share, 2017-2028
Figure 33. China Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2028
Figure 37. India Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Rheumatoid Arthritis Medicine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Rheumatoid Arthritis Medicine Sales Market Share, 2017-2028
Figure 40. Brazil Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Rheumatoid Arthritis Medicine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Rheumatoid Arthritis Medicine Sales Market Share, 2017-2028
Figure 44. Turkey Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Rheumatoid Arthritis Medicine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Rheumatoid Arthritis Medicine Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Rheumatoid Arthritis Medicine by Region, 2021 VS 2028
Figure 50. Rheumatoid Arthritis Medicine Industry Value Chain
Figure 51. Marketing Channels
